AbbVie reports two patient deaths in rheumatoid arthritis study

(Reuters) - AbbVie Inc said on Monday two patients died in a late-stage trial testing its drug to treat patients with moderate to severe rheumatoid arthritis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news